Financière de Tubize SA (EBR:TUB)
204.00
-7.50 (-3.55%)
At close: Mar 20, 2026
Financière de Tubize Market Cap
Financière de Tubize has a market cap or net worth of €9.08 billion as of March 20, 2026. Its market cap has increased by 48.69% in one year.
Market Cap
9.08B
Enterprise Value
9.08B
Revenue
13.26K
Ranking
n/a
PE Ratio
97.92
Stock Price
€204.00
Market Cap Chart
Since April 16, 2001, Financière de Tubize's market cap has increased from 1.37B to 9.08B, an increase of 562.01%. That is a compound annual growth rate of 7.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 9.08B | -2.39% |
| Dec 31, 2025 | 9.30B | 46.98% |
| Dec 31, 2024 | 6.33B | 98.33% |
| Dec 29, 2023 | 3.19B | 1.27% |
| Dec 30, 2022 | 3.15B | -21.59% |
| Dec 31, 2021 | 4.02B | 9.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UCB SA | 47.97B |
| argenx SE | 36.30B |
| Onward Medical | 196.31M |
| Hyloris Pharmaceuticals | 160.72M |
| European Medical Solutions | 20.74M |
| Celyad Oncology | 14.06M |
| BioSenic | 1.50M |
| Oxurion NV | 392.55K |